Skip to main content

Glimpses of stem cell medicine

After three days of discussions about stem cell machinery, the organizers concluded the linkurl:Keystone meeting;https://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=786 on stem cell biology today by treating participants to data showing what these cells can already do in humans. These efforts appear not quite as differentiated as stem cells themselves, but are hopefully on their way to becoming so. Tonight, Michele De Luca from the Veneto Eye Bank Foundation and the University o

Written byAlison McCook
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
After three days of discussions about stem cell machinery, the organizers concluded the linkurl:Keystone meeting;https://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=786 on stem cell biology today by treating participants to data showing what these cells can already do in humans. These efforts appear not quite as differentiated as stem cells themselves, but are hopefully on their way to becoming so. Tonight, Michele De Luca from the Veneto Eye Bank Foundation and the University of Modena in Italy presented a series of stomach-churning videos and images illustrating how he and his colleagues used autologous stem cells to correct both blindness and a rare, blistering skin disease. In a study involving nearly 200 people blinded after burns depleted their stores of limbal stem cells, stem cell transplants corrected the vision of the majority of patients, even several years after the operation. Another man with epidermolysis bullosa (EB), a disease in which the slightest trauma causes major damage to the skin, received transplants of his own genetically corrected epidermal stem cells, and experienced major improvements in the areas that received the transplant. Four months after the procedure, "there is a complete regeneration of the epidermis," De Luca told the audience. (Indeed, the pictures showed remarkable differences between the swaths of treated and untreated skin.) De Luca said he plans to continue the experiment, transplanting the rest of the patient?s skin "step by step." Following De Luca?s presentation, linkurl:Ronald McKay;https://intra.ninds.nih.gov/Lab.asp?Org_ID=25 from the National Institutes of Health estimated that as early as within the next several months, researchers might obtain dopamine neurons from human embryonic stem cells -- a potentially major advance for people diagnosed with Parkinson?s disease. However, he and his co-presenter, linkurl:Olle Lindvall;https://www.medfak.lu.se/stemcellcenter/olle_lindvall.htm from the Wallenberg Neuroscience Center in Lund, Sweden, cautioned against immediate enthusiasm. Lindvall noted that one first has to demonstrate that these new cells work, and work better than existing therapies, to justify testing them in humans. McKay agreed, noting that, despite the immediate need, it?s vital to first understand the developmental biology of the system before proceeding to the clinic. We even saw promising data from studies of man?s best friend, the dog -- in this case, golden retrievers with a form of muscular dystrophy. Curiously, the experiments, conducted by Giulio Cossu from the University La Sapienza in Italy, and his colleagues, showed that transplants of wild type donor stem cells appeared to work better than autologous, corrected stem cell transplants -- a finding deemed "amazing" by an audience member during the Question & Answer period following the presentation.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter
Optimizing SV-AUC for Peptide Therapeutic Analysis

Optimizing SV-AUC for Peptide Therapeutic Analysis

​Beckman Coulter
Engineering Bispecific Antibodies Against Emerging Viruses

Engineering Bispecific Antibodies Against Emerging Viruses

innovative-research-horizontal-lock-inverted-rgb-900px-w-72ppi

Products

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation

A photograph of plastic fragments floating in water, symbolizing contamination from sample storage tubes.

LVL SAFE® 2D-Coded Tubes: The Perfect Tube for Your Sample

AutoGen